Literature DB >> 18706847

[General mechanisms of premature ovarian failure and clinical check-up].

S Christin-Maitre1, R Braham.   

Abstract

Premature ovarian failure (POF) is defined as the cessation of ovarian function under the age of 40 years. It is characterized by primary or secondary amenorrhea for at least four months, sex steroid deficiency and elevated serum gonadotropin concentrations. The diagnosis is confirmed by the detection of menopausal FSH levels on at least two occasions a few weeks apart in a woman before the age of 40. It occurs in 1/10,000 in women below the age of 20, 1/1,000 below 30 and 1% in women before the age of 40. The classic etiologies are Turner syndrome, pelvic surgery, radiotherapy or chemotherapy. Although new genetic etiologies have been found in the past 10 years, the cause of POF is unknown in more than 75% of cases. Hormone replacement therapy should be administered in order to avoid vascular diseases and osteoporosis. For infertility, the most successful treatment remains assisted conception with donated oocytes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18706847     DOI: 10.1016/j.gyobfe.2008.07.003

Source DB:  PubMed          Journal:  Gynecol Obstet Fertil        ISSN: 1297-9589


  9 in total

Review 1.  Dynamics of the ovarian reserve and impact of genetic and epidemiological factors on age of menopause.

Authors:  Emanuele Pelosi; Eleanor Simonsick; Antonino Forabosco; Jose Elias Garcia-Ortiz; David Schlessinger
Journal:  Biol Reprod       Date:  2015-04-22       Impact factor: 4.285

2.  The protective effect of platelet-rich plasma administrated on ovarian function in female rats with Cy-induced ovarian damage.

Authors:  Pinar Ozcan; Taha Takmaz; Olgu Enis Tok; Sevde Islek; Esra Nur Yigit; Cem Ficicioglu
Journal:  J Assist Reprod Genet       Date:  2020-02-04       Impact factor: 3.412

3.  Steroidogenic factor-1 (SF-1) gene mutation as a frequent cause of primary amenorrhea in 46,XY female adolescents with low testosterone concentration.

Authors:  Pascal Philibert; Elodie Leprieur; Delphine Zenaty; Elisabeth Thibaud; Michel Polak; Anne-Marie Frances; James Lespinasse; Isabelle Raingeard; Nadège Servant; Françoise Audran; Françoise Paris; Charles Sultan
Journal:  Reprod Biol Endocrinol       Date:  2010-03-19       Impact factor: 5.211

4.  Long-term follow-up of fertility and pregnancy in autoimmune diseases after autologous haematopoietic stem cell transplantation.

Authors:  G Massenkeil; T Alexander; O Rosen; B Dörken; G Burmester; A Radbruch; F Hiepe; R Arnold
Journal:  Rheumatol Int       Date:  2016-08-13       Impact factor: 2.631

5.  Differentiation of primordial germ cells from premature ovarian insufficiency-derived induced pluripotent stem cells.

Authors:  Sheng Yang; Shufang Ding; Shiwei He; Lixia He; Kefei Gao; Shuping Peng; Cijun Shuai
Journal:  Stem Cell Res Ther       Date:  2019-05-31       Impact factor: 6.832

6.  Towards Cell free Therapy of Premature Ovarian Insufficiency: Human Bone Marrow Mesenchymal Stem Cells Secretome Enhances Angiogenesis in Human Ovarian Microvascular Endothelial Cells.

Authors:  Hang-Soo Park; Dalia Ashour; Amro Elsharoud; Rishi Man Chugh; Nahed Ismail; Abdeljabar El Andaloussi; Ayman Al-Hendy
Journal:  HSOA J Stem Cells Res Dev Ther       Date:  2019-11-06

7.  Safety of Intraovarian Injection of Human Mesenchymal Stem Cells in a Premature Ovarian Insufficiency Mouse Model.

Authors:  Hang-Soo Park; Rishi Man Chugh; Amro Elsharoud; Mara Ulin; Sahar Esfandyari; Alshimaa Aboalsoud; Lale Bakir; Ayman Al-Hendy
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

8.  Human BM-MSC secretome enhances human granulosa cell proliferation and steroidogenesis and restores ovarian function in primary ovarian insufficiency mouse model.

Authors:  Hang-Soo Park; Rishi Man Chugh; Abdeljabar El Andaloussi; Elie Hobeika; Sahar Esfandyari; Amro Elsharoud; Mara Ulin; Natalia Garcia; Mahmood Bilal; Ayman Al-Hendy
Journal:  Sci Rep       Date:  2021-02-25       Impact factor: 4.379

9.  Abnormally Elevated Follicle-Stimulating Hormone (FSH) Level in an Infertile Woman.

Authors:  Aurore Catteau; Kalyane Bach-Ngohou; Justine Blin; Paul Barrière; Thomas Fréour; Damien Masson
Journal:  Case Rep Endocrinol       Date:  2019-09-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.